絞り込み

16555

広告

スターを付ける スターを付ける     (8view , 0users)

Full Text Sources

Predicting relapse is a major challenge in schizophrenia from a clinical and medico-economic point of view. During recent decades, major psychiatric disorders have been found to be extensively associated with metabolic disorders, even before the illness onset, with a prevalence estimated to be 35% in this population. However, no study to date has, to our knowledge, explored the potential impact of metabolic syndrome (MetS) on relapse.
PMID: 30257079 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード